En español
NIDA

Primary Care Opioid Use Disorders Treatment Trial

Though treatment for opioid use disorders with medications (buprenorphine or naltrexone provided in primary care, or methadone from an Opioid Treatment Program) has been shown to be effective, the majority of patients with OUDs are never treated with medications, and most primary care practices do not offer buprenorphine treatment.  This trial seeks to compare a collaborative care model to “Usual Primary Care” for management of OUDs in primary care across multiple health care systems. 

CTN Protocol ID: 
CTN-0074
Status: 
Development
Principal Investigator(s)
Katharine Bradley, M.D., M.P.H.
Senior Investigator
Group Health Research Institute
Metropolitan Park East
1730 Minor Avenue, Ste. 1600
Seattle, WA 98101
bradley.k@ghc.org

Get this Publication

    Blending Initiative

    blending logo

    Formed with SAMHSA to reduce the gap between research results and treatment.